186 related articles for article (PubMed ID: 25989273)
1. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
[TBL] [Abstract][Full Text] [Related]
2. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
Chang DK; Jamieson NB; Johns AL; Scarlett CJ; Pajic M; Chou A; Pinese M; Humphris JL; Jones MD; Toon C; Nagrial AM; Chantrill LA; Chin VT; Pinho AV; Rooman I; Cowley MJ; Wu J; Mead RS; Colvin EK; Samra JS; Corbo V; Bassi C; Falconi M; Lawlor RT; Crippa S; Sperandio N; Bersani S; Dickson EJ; Mohamed MA; Oien KA; Foulis AK; Musgrove EA; Sutherland RL; Kench JG; Carter CR; Gill AJ; Scarpa A; McKay CJ; Biankin AV
J Clin Oncol; 2013 Apr; 31(10):1348-56. PubMed ID: 23439753
[TBL] [Abstract][Full Text] [Related]
3. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
5. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
6. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
10. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
11. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
Leo JM; Kalloger SE; Peixoto RD; Gale NS; Webber DL; Owen DA; Renouf D; Schaeffer DF
J Clin Pathol; 2016 May; 69(5):431-9. PubMed ID: 26500334
[TBL] [Abstract][Full Text] [Related]
13. Histologic subtype-based evaluation of recurrence and survival outcomes in patients with adenocarcinoma of the ampulla of Vater.
Park SJ; Shin K; Hong TH; Lee SH; Kim IH; Kim Y; Lee M
Sci Rep; 2023 Oct; 13(1):16547. PubMed ID: 37783755
[TBL] [Abstract][Full Text] [Related]
14. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
15. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
[TBL] [Abstract][Full Text] [Related]
16. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
Liu F; Shen D; Ma Y; Song Q; Wang H
J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
[TBL] [Abstract][Full Text] [Related]
17. Important prognostic factors in adenocarcinoma of the ampulla of Vater.
Lowe MC; Coban I; Adsay NV; Sarmiento JM; Chu CK; Staley CA; Galloway JR; Kooby DA
Am Surg; 2009 Sep; 75(9):754-60; discussion 761. PubMed ID: 19774945
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.
Sessa F; Furlan D; Zampatti C; Carnevali I; Franzi F; Capella C
Virchows Arch; 2007 Sep; 451(3):649-57. PubMed ID: 17653761
[TBL] [Abstract][Full Text] [Related]
19. Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study.
Perkins G; Svrcek M; Bouchet-Doumenq C; Voron T; Colussi O; Debove C; Merabtene F; Dumont S; Sauvanet A; Hammel P; Cros J; André T; Bachet JB; Bardier A; Douard R; Meatchi T; Peschaud F; Emile JF; Cojean-Zelek I; Laurent-Puig P; Taieb J
Br J Cancer; 2019 Apr; 120(7):697-702. PubMed ID: 30837681
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
